Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (62) 62
life sciences & biomedicine (61) 61
humans (49) 49
hematology (46) 46
oncology (34) 34
male (32) 32
antineoplastic combined chemotherapy protocols - therapeutic use (31) 31
female (31) 31
middle aged (26) 26
aged (25) 25
treatment outcome (24) 24
rituximab (20) 20
prognosis (19) 19
lymphoma (17) 17
adult (16) 16
lymphoma, large b-cell, diffuse - drug therapy (16) 16
lymphomas (14) 14
chemotherapy (13) 13
aged, 80 and over (11) 11
antibodies, monoclonal, murine-derived - administration & dosage (11) 11
antineoplastic combined chemotherapy protocols - administration & dosage (11) 11
antineoplastic combined chemotherapy protocols - adverse effects (11) 11
biological and medical sciences (10) 10
disease-free survival (10) 10
hematologic and hematopoietic diseases (10) 10
lymphoma, large b-cell, diffuse - mortality (10) 10
medical sciences (10) 10
young adult (10) 10
cyclophosphamide - administration & dosage (9) 9
cyclophosphamide - therapeutic use (9) 9
doxorubicin - administration & dosage (9) 9
doxorubicin - therapeutic use (9) 9
leukemias. malignant lymphomas. malignant reticulosis. myelofibrosis (9) 9
prednisone - administration & dosage (9) 9
prednisone - therapeutic use (9) 9
recurrence (9) 9
vincristine - administration & dosage (9) 9
vincristine - therapeutic use (9) 9
adolescent (8) 8
antibodies, monoclonal, murine-derived - therapeutic use (8) 8
cancer (8) 8
diffuse large b-cell lymphoma (8) 8
lymphoma, large b-cell, diffuse - pathology (8) 8
retrospective studies (8) 8
antibodies, monoclonal, murine-derived - adverse effects (7) 7
antineoplastic agents - therapeutic use (7) 7
cyclophosphamide - adverse effects (7) 7
doxorubicin - adverse effects (7) 7
hematology, oncology and palliative medicine (7) 7
prednisone - adverse effects (7) 7
stem cells (7) 7
transplantation (7) 7
vincristine - adverse effects (7) 7
antineoplastic agents (6) 6
b-cell lymphoma (6) 6
hemic and lymphatic diseases (6) 6
lymphoma, large b-cell, diffuse - genetics (6) 6
risk factors (6) 6
abridged index medicus (5) 5
clinical trials as topic (5) 5
combined modality therapy (5) 5
drug therapy (5) 5
follow-up studies (5) 5
gene expression (5) 5
lymphoma, b-cell - drug therapy (5) 5
lymphoma, large b-cell, diffuse - diagnosis (5) 5
lymphoma, non-hodgkin - drug therapy (5) 5
medical prognosis (5) 5
neoplasm staging (5) 5
stem cell transplantation (5) 5
survival analysis (5) 5
survival rate (5) 5
tumors (5) 5
age factors (4) 4
antibodies, monoclonal - administration & dosage (4) 4
antibodies, monoclonal, murine-derived (4) 4
antimitotic agents (4) 4
bone marrow (4) 4
care and treatment (4) 4
cytarabine (4) 4
genomics (4) 4
immune system diseases (4) 4
kaplan-meier estimate (4) 4
lymphocytes b (4) 4
lymphoma, b-cell - mortality (4) 4
lymphoma, b-cell - therapy (4) 4
lymphoma, large b-cell, diffuse - therapy (4) 4
mantle cell lymphoma (4) 4
mediastinal neoplasms - drug therapy (4) 4
methotrexate - administration & dosage (4) 4
prospective studies (4) 4
transplantation, autologous (4) 4
aggressive lymphoma (3) 3
bendamustine (3) 3
cancer research (3) 3
central nervous system neoplasms - prevention & control (3) 3
clinical medicine (3) 3
clinical trials (3) 3
consolidation chemotherapy (3) 3
cytarabine - administration & dosage (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Brentuximab vedotin-based salvage treatment in Hodgkin's lymphoma
by Vitolo, Umberto and Chiappella, Annalisa
The lancet oncology, ISSN 1470-2045, 09/2018, Volume 19, Issue 9, pp. 1144 - 1146
Life Sciences & Biomedicine | Oncology | Science & Technology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Salvage regimens for Hodgkin's lymphoma in the brentuximab vedotin era
by Vitolo, Umberto and Chiappella, Annalisa
The lancet oncology, ISSN 1470-2045, 02/2018, Volume 19, Issue 2, pp. 162 - 163
Life Sciences & Biomedicine | Oncology | Science & Technology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Selective inhibitors of nuclear export in aggressive B-cell lymphomas
by Chiappella, Annalisa and Corradini, Paolo
The Lancet. Haematology, ISSN 2352-3026, 07/2020, Volume 7, Issue 7, pp. e500 - e501
Life Sciences & Biomedicine | Hematology | Science & Technology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Rituximab Maintenance Compared With Observation After Brief First-Line R-FND Chemoimmunotherapy With Rituximab Consolidation in Patients Age Older Than 60 Years With Advanced Follicular Lymphoma: A Phase III Randomized Study by the Fondazione Italiana Linfomi
by Umberto Vitolo and Marco Ladetto and Carola Boccomini and Luca Baldini and Federico De Angelis and Alessandra Tucci and Barbara Botto and Annalisa Chiappella and Annalisa Chiarenza and Antonello Pinto and Amalia De Renzo and Francesco Zaja and Claudia Castellino and Alessia Bari and Isabel Alvarez De Celis and Andrea Evangelista and Guido Parvis and Enrica Gamba and Chiara Lobetti-Bodoni and Giovannino Ciccone and Giuseppe Rossi
Journal of clinical oncology, ISSN 0732-183X, 09/2013, Volume 31, Issue 27, pp. 3351 - 3359
Life Sciences & Biomedicine | Oncology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Tumors | Dexamethasone - administration & dosage | Lymphoma, Follicular - drug therapy | Age Factors | Mitoxantrone - administration & dosage | Lymphoma, Follicular - pathology | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Rituximab | Male | Consolidation Chemotherapy | Vidarabine - analogs & derivatives | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Female | Aged | Vidarabine - administration & dosage | Antibodies, Monoclonal, Murine-Derived - adverse effects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Monoclonal antibody-drug conjugates in B-cell lymphomas
by Chiappella, Annalisa and Vitolo, Umberto
The Lancet. Haematology, ISSN 2352-3026, 05/2019, Volume 6, Issue 5, pp. e232 - e233
Life Sciences & Biomedicine | Hematology | Science & Technology | Immunoconjugates - pharmacology | Humans | Immunotherapy | Lymphoma, B-Cell - diagnosis | Immunoconjugates - therapeutic use | Treatment Outcome | Combined Modality Therapy | Lymphoma, B-Cell - drug therapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Rituximab and autologous stem-cell transplantation for high-risk diffuse large B-cell lymphoma – Authors' reply
by Chiappella, Annalisa and Martelli, Maurizio and Evangelista, Andrea and Vitolo, Umberto
The lancet oncology, ISSN 1470-2045, 10/2017, Volume 18, Issue 10, pp. e558 - e558
Transplantation | Lymphomas | Stem cells | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Rituximab plus bendamustine as front-line treatment in frail elderly (>70 years) patients with diffuse large b-cell non-hodgkin lymphoma: A phase ii multicenter study of the fondazione italiana linfomi
by Storti, Sergio and Spina, Michele and Pesce, Emanuela Anna and Salvi, Flavia and Merli, Michele and Ruffini, Alessia and Cabras, Giuseppina and Chiappella, Annalisa and Angelucci, Emanuele and Fabbri, Alberto and Liberati, Anna Marina and Tani, Monica and Musuraca, Gerardo and Molinari, Annalia and Petrilli, Maria Pia and Palladino, Carmela and Ciancia, Rosanna and Ferrario, Andrea and Gasbarrino, Cristiana and Monaco, Federico and Fraticelli, Vincenzo and De Vellis, Annalisa and Merli, Francesco and Luminari, Stefano
Haematologica (Roma), ISSN 0390-6078, 07/2018, Volume 103, Issue 8, pp. 1345 - 1350
Life Sciences & Biomedicine | Hematology | Science & Technology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Epigenomic evolution in diffuse large B-cell lymphomas
by Pan, Heng and Jiang, Yanwen and Boi, Michela and Tabbò, Fabrizio and Redmond, David and Nie, Kui and Ladetto, Marco and Chiappella, Annalisa and Cerchietti, Leandro and Shaknovich, Rita and Melnick, Ari M and Inghirami, Giorgio G and Tam, Wayne and Elemento, Olivier
Nature communications, ISSN 2041-1723, 04/2015, Volume 6, Issue 1, pp. 6921 - 6921
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Biological Evolution | Recurrence | DNA Methylation | Epigenomics | Humans | Gene Expression Regulation, Neoplastic | Transcriptome | Lymphoma, Large B-Cell, Diffuse - metabolism | Gene Regulatory Networks | Neoplasm Proteins - genetics | Neoplasm Proteins - metabolism | Lymphoma, Large B-Cell, Diffuse - genetics | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Time to progression of mantle cell lymphoma after high‐dose cytarabine‐based regimens defines patients risk for death
by Visco, Carlo and Tisi, Maria C and Evangelista, Andrea and Di Rocco, Alice and Zoellner, Anna‐Katharina and Zilioli, Vittorio R and Hohaus, Stefan and Sciarra, Roberta and Re, Alessandro and Tecchio, Cristina and Chiappella, Annalisa and Morello, Lucia and Gini, Guido and Nassi, Luca and Perrone, Tommasina and Molinari, Anna L and Fabbri, Alberto and Cox, Maria C and Finolezzi, Erica and Ferrero, Simone and Puccini, Benedetta and Alvarez De Celis, Isabel and Arcari, Annalisa and Marino, Dario and Merli, Michele and Piazza, Francesco and Gentile, Massimo and Pelosini, Matteo and Loseto, Giacomo and Hermine, Olivier and Dreyling, Martin and Ruggeri, Marco and Martelli, Maurizio and Hoster, Eva and Vitolo, Umberto and Fondazione Italiana Linfomi Mantle and Fondazione Italiana Linfomi and the Mantle Cell Lymphoma Network and for the Fondazione Italiana Linfomi and the Mantle Cell Lymphoma Network
British journal of haematology, ISSN 0007-1048, 06/2019, Volume 185, Issue 5, pp. 940 - 944
cytarabine | refractory | mantle cell lymphoma | allogeneic transplant | prognosis | Life Sciences & Biomedicine | Hematology | Science & Technology | Lymphomas | Lymphoma | Cytarabine | Mantle cell lymphoma | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Lenalidomide plus R-CHOP21 in elderly patients with untreated diffuse large B-cell lymphoma: results of the REAL07 open-label, multicentre, phase 2 trial
by Vitolo, Umberto, Dr and Chiappella, Annalisa, MD and Franceschetti, Silvia, MD and Carella, Angelo Michele, MD and Baldi, Ileana, PhD and Inghirami, Giorgio, Prof and Spina, Michele, MD and Pavone, Vincenzo, MD and Ladetto, Marco, MD and Liberati, Anna Marina, Prof and Molinari, Anna Lia, MD and Zinzani, Pierluigi, Prof and Salvi, Flavia, MD and Fattori, Pier Paolo, MD and Zaccaria, Alfonso, MD and Dreyling, Martin, Prof and Botto, Barbara, MD and Castellino, Alessia, MD and Congiu, Angela, MD and Gaudiano, Marcello, PhD and Zanni, Manuela, MD and Ciccone, Giovannino, MD and Gaidano, Gianluca, Prof and Rossi, Giuseppe, MD and on behalf of the Fondazione Italiana Linfomi and Fdn Italiana Linfomi and Fondazione Italiana Linfomi
The lancet oncology, ISSN 1470-2045, 2014, Volume 15, Issue 7, pp. 730 - 737
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Thalidomide - adverse effects | Cyclophosphamide - administration & dosage | Prednisone - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Lymphoma, Large B-Cell, Diffuse - drug therapy | Prednisone - adverse effects | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Thalidomide - administration & dosage | Cyclophosphamide - adverse effects | Lymphoma, Large B-Cell, Diffuse - mortality | Thalidomide - analogs & derivatives | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged, 80 and over | Vincristine - administration & dosage | Vincristine - adverse effects | Female | Aged | Antibodies, Monoclonal, Murine-Derived - adverse effects | Doxorubicin - adverse effects | Doxorubicin - administration & dosage | Aged patients | Anthracyclines | Product development | Corticosteroids | Angiogenesis inhibitors | Public health | Analysis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study
by Chiappella, Annalisa and Martelli, Maurizio and Angelucci, Emanuele and Brusamolino, Ercole and Evangelista, Andrea and Carella, Angelo Michele and Stelitano, Caterina and Rossi, Giuseppe and Balzarotti, Monica and Merli, Francesco and Gaidano, Gianluca and Pavone, Vincenzo and Rigacci, Luigi and Zaja, Francesco and D'Arco, Alfonso and Cascavilla, Nicola and Russo, Eleonora and Castellino, Alessia and Gotti, Manuel and Congiu, Angela Giovanna and Cabras, Maria Giuseppina and Tucci, Alessandra and Agostinelli, Claudio and Ciccone, Giovannino and Pileri, Stefano A and Vitolo, Umberto
The lancet oncology, ISSN 1470-2045, 08/2017, Volume 18, Issue 8, pp. 1076 - 1088
Life Sciences & Biomedicine | Oncology | Science & Technology | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Follow-Up Studies | Mitoxantrone - administration & dosage | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Induction Chemotherapy | Male | Transplantation, Autologous | Consolidation Chemotherapy | Cyclophosphamide - adverse effects | Lymphoma, Large B-Cell, Diffuse - therapy | Vincristine - administration & dosage | Adult | Female | Doxorubicin - administration & dosage | Hematologic Diseases - chemically induced | Prednisone - administration & dosage | Dexamethasone - administration & dosage | Prednisone - adverse effects | Risk Factors | Etoposide - administration & dosage | Survival Rate | Cytarabine - administration & dosage | Rituximab - administration & dosage | Disease-Free Survival | Melphalan - administration & dosage | Intention to Treat Analysis | Vincristine - adverse effects | Antibodies, Monoclonal, Murine-Derived - adverse effects | Doxorubicin - adverse effects | Carmustine - administration & dosage | Stem Cell Transplantation - adverse effects | Stem cells | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Intensified therapy in diffuse large B-cell lymphoma
by Novo, Mattia and Castellino, Alessia and Chiappella, Annalisa
Oncotarget, ISSN 1949-2553, 2018, Volume 9, Issue 16, pp. 12548 - 12549
Autologous stem cell transplant | High risk | High-dose chemotherapy | Poor prognosis | Diffuse large B-cell lymphoma
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Diffuse large B cell lymphoma cell of origin by digital expression profiling in the REAL07 Phase 1–2 study
by Cascione, Luciano and Rinaldi, Andrea and Chiappella, Annalisa and Kwee, Ivo and Ciccone, Giovannino and Altenbuchinger, Michael and Kohler, Christian and Vitolo, Umberto and Inghirami, Giorgio and Bertoni, Francesco
British journal of haematology, ISSN 0007-1048, 08/2018, Volume 182, Issue 3, pp. 453 - 456
lenalidomide | diffuse large B cell lymphoma | Nanostring | gene expression | lymphoma | Life Sciences & Biomedicine | Hematology | Science & Technology | Doxorubicin - therapeutic use | Lymphoma, Large B-Cell, Diffuse - pathology | Humans | Treatment Outcome | Gene Expression Profiling | Cell Lineage - drug effects | Cyclophosphamide - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Lenalidomide - therapeutic use | Vincristine - therapeutic use | Aged | B-Lymphocytes - pathology | Prednisone - therapeutic use | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Gene expression | Lymphomas | Profiling | Lymphocytes B | Lymphoma | B-cell lymphoma
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Brentuximab vedotin in relapsed primary mediastinal large B-cell lymphoma: Results from a phase 2 clinical trial
by Zinzani, Pier Luigi and Pellegrini, Cinzia and Chiappella, Annalisa and Di Rocco, Alice and Salvi, Flavia and Cabras, Maria Giuseppina and Argnani, Lisa and Stefoni, Vittorio
Blood, ISSN 0006-4971, 04/2017, Volume 129, Issue 16, pp. 2328 - 2330
Life Sciences & Biomedicine | Hematology | Science & Technology | Recurrence | Lymphoma, Large B-Cell, Diffuse - drug therapy | Humans | Middle Aged | Male | Mediastinal Neoplasms - mortality | Survival Rate | Immunoconjugates - administration & dosage | Lymphoma, Large B-Cell, Diffuse - mortality | Disease-Free Survival | Mediastinal Neoplasms - drug therapy | Adult | Female | Aged | Brentuximab Vedotin | Immunoconjugates - adverse effects | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. ROBUST: Lenalidomide-R-CHOP versus placebo-R-CHOP in previously untreated ABC-type diffuse large B-cell lymphoma
by Nowakowski, Grzegorz S and Chiappella, Annalisa and Witzig, Thomas E and Spina, Michele and Gascoyne, Randy D and Zhang, Lei and Flament, Jocelyne and Repici, Jacqueline and Vitolo, Umberto
Future oncology (London, England), ISSN 1479-6694, 07/2016, Volume 12, Issue 13, pp. 1553 - 1563
hematologic/lymphoma | molecular oncology | chemotherapy | Life Sciences & Biomedicine | Oncology | Science & Technology | Cyclophosphamide - administration & dosage | Prednisone - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Lymphoma, Large B-Cell, Diffuse - drug therapy | Double-Blind Method | Humans | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Male | Thalidomide - administration & dosage | Thalidomide - analogs & derivatives | Vincristine - administration & dosage | Female | Research Design | Doxorubicin - administration & dosage
Journal Article
Details down arrow
16. Full Text First-Line Treatment for Primary Testicular Diffuse Large B-Cell Lymphoma With Rituximab-CHOP, CNS Prophylaxis, and Contralateral Testis Irradiation: Final Results of an International Phase II Trial
by Umberto Vitolo and Annalisa Chiappella and Andrés J.M. Ferreri and Maurizio Martelli and Ileana Baldi and Monica Balzarotti and Chiara Bottelli and Annarita Conconi and Henry Gomez and Armando Lopez-Guillermo and Giovanni Martinelli and Francesco Merli and Domenico Novero and Lorella Orsucci and Vincenzo Pavone and Umberto Ricardi and Sergio Storti and Mary K. Gospodarowicz and Franco Cavalli and Andreas H. Sarris and Emanuele Zucca
Journal of clinical oncology, ISSN 0732-183X, 07/2011, Volume 29, Issue 20, pp. 2766 - 2772
Life Sciences & Biomedicine | Oncology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Tumors | Doxorubicin - therapeutic use | Recurrence | Prospective Studies | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Testicular Neoplasms - pathology | Central Nervous System Neoplasms - secondary | Testicular Neoplasms - radiotherapy | Central Nervous System Neoplasms - prevention & control | Drug-Related Side Effects and Adverse Reactions | Adult | Lymphoma, Large B-Cell, Diffuse - drug therapy | Prednisone - adverse effects | Lymphoma, Large B-Cell, Diffuse - pathology | Rituximab | Treatment Outcome | Lymphoma, Large B-Cell, Diffuse - radiotherapy | Methotrexate - adverse effects | Testicular Neoplasms - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | Vincristine - therapeutic use | Vincristine - adverse effects | Methotrexate - administration & dosage | Aged | Antibodies, Monoclonal, Murine-Derived - adverse effects | Doxorubicin - adverse effects | Prednisone - therapeutic use | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights